MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
66.82
-1.27
-1.87%
After Hours: 67.00 +0.18 +0.27% 19:56 09/04 EDT
OPEN
67.24
PREV CLOSE
68.09
HIGH
67.72
LOW
66.58
VOLUME
4.83M
TURNOVER
--
52 WEEK HIGH
68.64
52 WEEK LOW
41.13
MARKET CAP
136.49B
P/E (TTM)
14.72
1D
5D
1M
3M
1Y
5Y
1D
Will Long‑Term Camzyos Data and Real‑World Evidence Change Bristol Myers Squibb's (BMY) Narrative?
Simply Wall St · 15h ago
Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial
TipRanks · 18h ago
Novartis, Bristol Myers Put Autoimmune CAR-T Trials on Ice as Safety Fears Explode
Benzinga · 19h ago
Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects -- Update
The Wall Street Journal · 21h ago
Bristol Myers Squibb: Still Cheap, Despite What The Chart Says
Seeking Alpha · 21h ago
Bristol Myers Squibb: Buy The Growth Portfolio At A Value Price
Seeking Alpha · 1d ago
*Novartis Didn't Disclose Trial Deaths Until After Analyst Noticed Study Pause, Analyst Says
The Wall Street Journal · 1d ago
*Drugmaker Paused Autoimmune Trials in June, Bristol Myers Says
The Wall Street Journal · 1d ago
More
About BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene maraleucel), Opdualag (nivolumab and relatlimab-rmbw), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), Sotyktu (deucravacitinib), Krazati (adagrasib), and Cobenfy (xanomeline and trospium chloride). Its other growth products include Augtyro, Onureg, Inrebic, Nulojix, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension).

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.